Featured Issue Briefs

The Battle on the Home Front: Jonathan Gadsden's Story

The Battle on the Home Front: Jonathan Gadsden's Story

Marine Lance Corporal's story reflects the growing need for new antibiotics that can treat dangerous diseases, against which most drugs are useless. Read More

Facilitating Medical Device Innovation: De Novo Reform

Facilitating Medical Device Innovation: De Novo Reform

The de novo process -- which requests lower-risk reclassification of medical devices and entry into the marketplace -- as it exists now is not achieving its purpose and has instead added unnecessary and time-consuming requirements. Read More

Food Products Recalled by FDA

Food Products Recalled by FDA

Since President Obama signed the FDA Food Safety Modernization Act into law, at least 149 FDA-regulated food products have been recalled due to potential pathogenic contamination. Read More

More Issue Briefs

# results: 61-70 of 194
Show items per page
Date Issue Briefs Topic
Apr 23, 2012

Save Antibiotics April Newsletter (2012)

Below is your April 2012 newsletter from  the Pew Campaign on Human Health and Industrial Farming. In this edition: FDA Takes Important Step to Curb Antibiotic Overuse in Food Animal Production.

More

Antibiotics in Food Animal Production

Apr 18, 2012

Testimony before the Committee on Energy and Commerce Subcommittee on Health

U.S. House of Representatives PDF Download Since 1992, user fee agreements have given FDA significant and sustained resources that allow the agency to review new products quickly. In fact, preliminary findings of a study that Pew has funded show that FDA reviews new drugs faster than its cou

More

Drug Safety

Apr 12, 2012

Reviving the Pipeline of Life-Saving Antibiotics

Antibiotic-resistant infections are a growing public health threat. At the same time, antibiotic innovation is waning. Pew, the IIDSA and PhRMA hosted a one-day conference, Reviving the Pipeline of Life-Saving Antibiotics: Exploring Solutions to Spur Innovation on September 22, 2011, exploring ways to overcome the challenges that hinder the development of new antibiotics.

More

Drug Safety, Antibiotic Innovation

Apr 11, 2012

Focus Group Findings on Prepaid Debit Cards

This fact sheet focuses on the lessons learned from consumers who purchase and use prepaid debit cards.

More

Checking, Credit Cards

Apr 3, 2012

MRSA: A Deadly Pathogen with Fewer and Fewer Treatment Options

Staphylococcus aureus, or staph, is a common bacterium that exists in our environment and our bodies. Most of the time it does no harm. Sometimes, however, it can cause infection and require treatment. MRSA refers to strains of S. aureus that are resistant to the antibiotic methicillin and a host of other drugs used to treat infection.

More

Food Safety, Antibiotic Innovation

Mar 30, 2012

Antibiotic Innovation: The Threat and the Pipeline

The Superbug Threat explores the emergence of antibiotic resistant bacteria and its impact on human health, as well as the shrinking pipeline of new antibiotics.

More

Antibiotics in Food Animal Production

Mar 29, 2012

Testimony before the Senate Committee on Health, Education, Labor and Pensions

Allan Coukell, Director of Medical Programs, Pew Health Group: Chairman Harkin, Ranking Member Enzi, and members of this committee, thank you for the opportunity to testify about the importance of the user fee agreement legislation to patients.

More

Drug Safety, Drugs and Devices at the FDA

Mar 8, 2012

Testimony of Allan Coukell on the Lack of a National Pharmaceutical Tracking System

On March 8, 2012, Pew Health Group’s Director of Medical Programs Allan Coukell testified before the Energy and Commerce Committee’s Subcommittee on Health regarding the drug distribution system – the risks of counterfeit and stolen drugs, and the pragmatic steps Congress can take to reduce those risks.

More

Drug Manufacturing and Distribution, Drug Safety

Mar 8, 2012

Testimony before the House Committee on Energy and Commerce, Subcommittee on Health

Allan Coukell, Director of Medical Programs, and Sharon Ladin, Director of the Antibiotics and Innovation Project, testify before the House Committee on Energy and Commerce, Subcommittee on Health on stimulating the development of new antibiotics urgently needed to fight serious and life-threatening bacterial infections.

More

Drug Safety, Antibiotic Innovation

Mar 1, 2012

Moms for Antibiotic Awareness March Newsletter (2012)

Below is your March 2012 newsletter from Moms for Antibiotic Awarness. In this edition: "Supermoms Against Superbugs" Take Washington By Storm Contest!; FDA Finds Rise in Antibiotic-Resistant Bacteria on Meat and Poultry

More

Antibiotics in Food Animal Production